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Abstract
This study elucidates exposure-response relationships between repetitive tasks, inflammation and
motor changes with work-related musculoskeletal disorders. Using a rat model of reaching and
handle-pulling, we examined effects of performing a high repetition low force (HRLF), low
repetition high force (LRHF), or high repetition high force (HRHF) task (2 h/day, 3 days/wk, 12
wks) on reach rate and force, percent success, duration of participation and grip strength. Reach
rate and reach force improved with HRLF, and percent success increased in all groups in week 9,
and HRLF and HRHF in week 12, indicative of skill acquisition. Duration and grip strength
showed force-dependent declines with task performance. A subset of HRHF rats received
ibuprofen in weeks 5–12. Ibuprofen significantly improved reach rate, reach force and duration in
treated rats, indicative of an inflammatory influence on reach performance. Ibuprofen improved
percent successful reaches in week 9, although this increase was not sustained. However, declines
in grip strength, a nocifensive behavior, were not prevented by ibuprofen. Examination of cervical
spinal cords of untreated and ibuprofen treated HRHF rats showed increased IL-1beta, an
inflammatory cytokine, in neurons. These findings suggest that only a preventive intervention
could have addressed all motor declines.
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Introduction
Work-related musculoskeletal disorders (WMSDs) can be caused by extended performance
of repetitive, forceful and/or awkward movements. WMSDs include diagnoses such as
tendinopathies, nerve compression syndromes, and muscular and joint disorders (Byl &
Melnick, 1997; Hales & Bertsche, 1992; Piligian et al., 2000; Rempel, 1992; Rempel,
Harrison, & Barnhart, 1992). The National Occupational Research Agenda (Marras, Cutlip,
Burt, & Waters, 2011) emphasizes the need for research to elucidate the exposure-dependent
nature of WMSDs and to develop effective preventions.
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Several animal studies of repetitive prehensile tasks have shown that repetitive hand opening
and closing induces motor dysfunction (Barbe et al., 2003; Barbe et al., 2008; Byl, Holland,
Jurek, & Hu, 1997; Byl et al., 1997; Byl, Merzenich & Jenkins, 1996; Clark, Al-Shatti, Barr,
Amin & Barbe, 2004; Coq et al., 2009; Elliott, Barr, Clark, Wade & Barbe, 2010; Elliott et
al., 2008; Rani, Barbe, Barr & Litvin, 2010; Sommerich et al., 2007; Topp & Byl, 1999). We
have developed a rat model of voluntary, repetitive reaching and grasping. When examining
the effects of performing either a high repetition or low repetition food retrieval task (a
negligible force task), we observed exposure-dependent decreases in reach performance and
grip strength, and the emergence of abnormal movement patterns (Barbe et al., 2003; Barbe
et al., 2008; Clark et al., 2003; Coq et al., 2009; Elliott et al., 2008). With both tasks, reach
performance declines were transient. However, grip strength declines and abnormal
movement patterns were greater with the high repetition, negligible force task. Performance
of a high repetition, high force handle-pulling task induced even greater declines in grip
strength and reach performance (Clark et al., 2004; Fedorczyk et al., 2010; Rani et al.,
2010). This handle-pulling task, in which rats can be trained to perform at a variety of reach
rates and force levels, was used in this current study to examine exposure-dependent motor
declines and potential contributing mechanisms.
The underlying mechanisms leading to the motor behavior changes associated with WMSDs
continue to be insufficiently understood. These mechanisms need to be clarified in order to
develop effective interventions. We previously proposed a conceptual model in which three
key interrelated pathways (peripheral tissue injury/inflammation, peripheral tissue
reorganization, and central nervous system reorganization) can drive further inflammatory
responses, adaptive or pathological tissue remodeling, and sensorimotor behavioral changes,
with performance of repetitive tasks (Barbe & Barr, 2006).
With regard to inflammation and motor behavior, forelimb grip strength declines occur after
intramuscular injections of inflammatory/pro-nociceptive cytokines, such as tumor necrosis
factor (TNF), into forelimb muscles (Schafers, Sorkin & Sommer, 2003; Beyreuther, Geis,
Stohr & Sommer, 2007). Grip strength also correlates negatively with inflammatory
cytokine levels in forelimb muscles of rats performing repetitive tasks for extended periods
(Barbe et al., 2008; Fedorczyk et al., 2010; Elliott et al., 2010). However, we have observed
that, although a two-week treatment with an anti-TNF alpha drug returned serum and tissue
cytokines to baseline levels, it only attenuated, but did not restore, grip strength declines
already present at the time of drug administration (Rani et al., 2010). This latter finding
suggests that there are contributing factors other than inflammation to declines in grip
strength.
Central nervous system changes can contribute to skill acquisition, but also to motor control
declines. Movement dysfunction has been attributed to degradation of the somatotopic
representation of the forepaw or hand in the primary somatosensory cortex in owl monkeys
and rats performing repetitive tasks (Byl et al., 1996; Byl et al., 1997; Topp & Byl, 99; Coq
et al., 2009) and human subjects with severe and moderate focal hand dystonia (Byl,
McKenzie & Nagarajan, 2000; Byl, Nagarajan, Merzenich, Roberts & McKenzie, 2002).
Furthermore, the emergence of nocifensive motor behaviors has been linked to maladaptive
changes in the spinal cord, such as increased pro-inflammatory cytokines in neurons or glia,
as a consequence of peripheral tissue injury or inflammation (Moalem & Tracey, 2006;
Hunt, Winkelstein, Rutkowski, Weinstein & DeLeo, 2001; Elliott et al., 2010).
Therefore, we extended previous studies to examine exposure-dependent changes in several
motor behaviors occurring with performance of a handle-pulling task for 9–12 weeks at 3
different repetition and force levels: 1) low repetition with high force, 2) high repetition with
low force, and 3) high repetition with high force. We also sought to determine if
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administration of a conservative anti-inflammatory drug, ibuprofen, as a secondary
intervention would effectively ameliorate motor declines in animals exposed to the HRHF
task. Based on our conceptual model, we hypothesize that although some voluntary reach
performance outcomes will improve due to skill acquisition, others will decline in an
exposure-dependent manner due to underlying inflammatory responses and that ibuprofen
treatment will effectively attenuate these latter declines. However, since reduced grip
strength can be a nocifensive reflexive behavior, we hypothesize that grip strength declines
will persist due to central nervous system changes, such as increased inflammatory
cytokines in spinal cord segments, which are not attenuated by ibuprofen treatment.
Methods
Overview
Using our model of a voluntary repetitive upper limb reaching and handle-pulling task in
rats, we compared voluntary reach performance outcomes in weeks 9 and 12 of task
performance to week 1 (the first week rats began performing the tasks for 2 hours/day, 3
days/week). We also compared reflexive grip strength in weeks 9 and 12 of task
performance to baseline naïve values. The independent variable was exposure to 1 of 3
different repetitive tasks: 1) a low repetition with high force task (LRHF), 2) a high
repetition with low force task (HRLF), or 3) a high repetition with high force task (HRHF).
A subcohort of the HRHF group began receiving ibuprofen treatment at the end of week 4
(HRHF+IBU), and the effects of this treatment to week 12 was compared to untreated
HRHF rats. Dependent variables included reach rate (includes successful and unsuccessful
reaches), reach force, percent successful reaches, duration of task participation (expressed as
a percentage of continuous participation for 120 min), and grip strength.
Animals
All experiments were approved by the Temple University Institutional Animal Care and Use
Committee and were in compliance with NIH guidelines for humane care and use of
laboratory animals. A total of 96 young adult (14 weeks of age at onset of study) female
Sprague-Dawley rats were used (Fig. 1). Female rats were used since human females have a
higher incidence of WMSDs than males (Gerr et al., 2002). The rats were housed in a central
animal facility in separate cages with a 12 hour light:dark cycle and free access to water. All
rats received food pellet rewards and Purina rat chow daily.
Behavioral Apparatuses
The behavioral apparatuses used were as previously described (Clark et al., 2004; Fedorczyk
et al., 2010). Briefly, custom-designed force apparatuses (Custom Medical Research
Equipment, Glendora, NJ) were integrated into an operant behavioral training system (Med
Associates, Georgia, VT). Animals reached through a shoulder height portal and then
isometrically pulled a force handle attached to a force transducer (Futek Advanced Sensor
Technology, Irvine, CA) located outside the chamber wall. The load cell was interfaced with
Force-Lever software (version 1.03.02, Med Associates, St. Albans, VT). An auditory
indicator cued the animals to reach once every 15 seconds, i.e. 4 reaches/min for high
repetition tasks, or to reach once every 30 seconds, i.e. 2 reaches/min, for the low repetition
task. The rats had to grasp the force handle and exert an isometric pull for at least 50 ms
with a graded force effort of either 15% (± 5%) of maximum voluntary pulling force for the
low force task, or 60% (± 5%) for high force tasks. If these criteria were met within a 5
second cueing period, a 45 mg purified formula food pellet (Bioserve, NJ) was dispensed
into a trough located at floor height for the animal to lick up. Animals were allowed to use
their preferred limb to reach. The contralateral limb was used as a postural support limb
throughout the task, with the rats often pushing with this limb against the chamber wall as
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they performed the isometric pull with the reach limb (as depicted in Fedorczyk et al.,
2010).
Initial training to learn the tasks
All rats except for normal controls were food-restricted for a short period (no more than 7
days) to 85–95% of their naive weight to initiate interest in the food pellets. After that first
week, rats were given extra rat chow, weighed weekly, and maintained thereafter as closely
as possible to within ± 5% of age matched normal control rats (used for weight comparison
only) until euthanasia. Thee food restricted rats went through an initial training period of
10–15 min/day, 5 days/week, for 5–6 weeks (see Fig. 1). During this period, they were
trained to perform the reaching and handle-pulling tasks at the appropriate reach rate and
force requirements for a particular task, as previously described (Clark et al., 2003; Elliott et
al., 2010).
HRLF, LRHF, HRHF Task regimens
After the training period, 92 rats began the task regimens for 2 hrs/day, 3 days/wk for up to
12 weeks: LRHF, n=18; HRLF, n=26; HRHF, n= 48 (Fig. 1). The task was divided into 4,
0.5-hr sessions separated by 1.5 hrs in order to avoid satiation. HRLF rats were cued to
reach at a target rate of 4 reaches/min, grasp the force handle and exert an isometric pull for
at least 50 ms at a force effort of 15% (± 5%) of the average maximum pulling force, as
previously described (Elliott et al., 2010). LRHF rats were cued to reach at a target rate of 2
reaches/min, and grasp the force handle at a force effort of 60% (± 5%). HRHF rats were
cued to reach at a target rate of 4 reaches/min, and grasp the force handle at a force effort of
60% (± 5%), as previously described (Clark et al., 2004; Driban, Barr, Amin, Sitler &
Barbe, 2011). If they either undershot the minimum criterion or overshot the maximum
criterion, no food reward was delivered. Because the inherent nature of our task is voluntary,
the rats tended to reach more frequently than the target rate, as described further in the
results. In addition, they were not prevented from reaching at a higher or lower force than
their target force. Thus, the animals were allowed to self-regulate their participation in task
performance, making these voluntary tasks. However, the food reward was not given unless
they met the force criterion within a 5 second window initiated every 15 (high repetition) or
30 seconds (low repetition), and held the handle with the correct force for 50 ms.
Ibuprofen Treatment of a cohort of HRHF group
At the end of the 4th week of task performance, a subcohort of 22 (Fig. 1), of the HRHF
animals were administered ibuprofen (Children’s Motrin Grape Flavored, Johnson &
Johnson) (HRHF+IBU) in drinking water daily (45 mg/kg body weight) as previously
described (Driban et al., 2011). The HRHF+IBU animals continued to perform the HRHF
task regimen with ibuprofen treatment for the remainder of the 12 week task period (i.e.,
throughout an 8 week course of ibuprofen treatment). The amount of medicated water
consumed/day was tracked for each animal and serum levels of ibuprofen were confirmed
using National Medical Services (Willow Grove, PA). Based on these assessments, the
average weekly ibuprofen dose was 48.8 ± 6.3 mg/kg body weight.
Determination of Reach Performance Behaviors
Force lever data were recorded continuously during each task session for later calculation of
the dependent variables (reach rate, reach force, percent of successful reaches, and duration)
via an automated script (MatLab; Mathworks, Natick, MA). A reach was defined as a force
deflection that exceeds 2.5% of the baseline (or zero) force until the next sample in which
the force falls below 2.5% of baseline. In this way, unsuccessful reaches that did not meet
the food reward criteria were recorded and analyzed along with successful reaches. Thus,
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reach rate was defined as the average number of both successful and unsuccessful reaches
performed per minute. Reach force was the average force (expressed as a percentage of
maximum pulling force) applied to the force handle for all reaches on a given day. The
average percent of successful reaches was determined by dividing the number of successful
reaches (in which the food reward criteria were met) by the total number of reaches, then
multiplying by 100. Duration was defined as the number of minutes (expressed as a
percentage of the target of 120 minutes) the rats participated in the task. Data for each
variable was calculated on the last day of week 1, 9 and 12.
Force lever data were obtained from: a) 15 HRLF animals at weeks 1, 9, and 12 of HRLF
task performance; b) 12 LRHF animals at weeks 1, 9, and 12 of LRHF task performance, c)
26 untreated HRHF animals at week 1 of HRHF task performance, with 18 animals
continuing to week 9 and 10 animals continuing to week 12 (the number reduces across
weeks due to euthanasia for other analyses); and d) 8 HRHF+IBU animals at week 1 (prior
to ibuprofen treatment), and at weeks 9 and 12 (after 5 and 8 weeks of ibuprofen treatment,
respectively). Week 1 was used as the baseline for reach performance variables since that
was the first week rats actually performed the task regimens for 2 hours/day, 3 days/week.
Grip Strength Analysis
Grip strength of the reach and support forelimb was tested in all task rats (HRLF n=26,
LRHF n=18, untreated HRHF n=26, and HRHF+IBU n=22; Fig. 1), at baseline before
training and task performance (the naïve time point), and in weeks 9 and 12, as previously
described, using a grip strength meter for rodents (Stoelting, Wood Dale, IL, USA) (Elliott
et al., 2010). Naïve data were used for baseline grip strength values since we have
previously reported a training effect for grip strength (Elliott et al., 2010). Maximum grip
strength was defined as the value of the peak force (in grams) recorded from the transducer
at the moment that forepaw grip strength is overcome by the examiner. Importantly, the
moment at which each animal released its grip from the handle of the grip strength meter
was self-determined. Therefore, the amplitude of force generated were influenced by several
factors, e.g. muscle inflammation, connective tissue changes, or spinal cord or brain
neuroplasticity, that can influence behavioral performance, as described previously
(Schafers et al. 2003; Elliott, Barr & Barbe 2009a; Coq et al, 2009). The test was repeated
five times per forelimb, in a randomized fashion for right versus left limbs, and the
maximum grip force (strength in grams) per trial was included in the statistical analysis. The
person carrying out the testing was blind to treatment.
Examination of Spinal Cord
Subcohorts of the HRHF and HRHF+IBU rats (n=4/group), as well as normal control rats
(n=4) that were not exposed to the training or tasks, were euthanized with an overdose of
sodium pentobarbital (120 mg/kg body weight), perfused intracardially with 4%
paraformaldehyde in phosphate buffer, and the cervical segments of the spinal cords
collected and sectioned as previously described (Elliott et al., 2010). The spinal cord
sections were then immunostained for interleukin-1 beta (IL-1beta; a pro-inflammatory
cytokine) and NeuN (a neuronal cell body marker), and then incubated in appropriate
secondary antibodies tagged to green (Cy2) or red (Cy3) fluorescent markers, using
previously described methods (Elliott et al., 2010). The ventral horns of the cervical spinal
cord were examined qualitatively for presence of cells immunostained for IL-1beta.
Statistical Analyses
To determine the effect of task performance on reach performance variables, two-way
ANOVAs were used with the following factors: week (weeks 1, 9 and 12 of task
performance) and group (HRLF, LRHF, HRHF and HRHF+IBU). To determine the effect of
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task performance on grip strength, two-way ANOVAs were used with the following factors:
week (naïve, and weeks 9 and 12 of task performance) and group (HRLF, LRHF, HRHF and
HRHF+IBU). A repeated measures ANOVA could not be used since the number of animals
per week differed across weeks and groups due to euthanasia and tissue collection for other
studies. The Bonferroni post-hoc method for multiple comparisons was used to compare
behavioral results in week 9 and 12 to week 1 or naive data (within group comparisons), and
to compare between groups at matching temporal endpoints (inter-group comparisons).
Adjusted P-values are reported. Data are expressed as mean ± standard error of the mean
(SEM).
Results
Concerning reach rate, because the inherent nature of our task is voluntary, the rats tended to
reach and pull more frequently than their target rates (Fig. 2), albeit not all of these were
successful reaches (see Fig. 4). The actual reach rate of the HRLF rats in week 1 was 20.7
reaches/min, approximately five times the target rate. The actual reach rate of the LRHF rats
in week 1 was 7.2 reaches/min, and the actual reach rate of the HRHF rats in week 1 was
13.42 reaches/min, each over 3 times their target rate. Since the reach rate variable includes
both successful and unsuccessful reaches, these results suggest that the rats did not rely
completely on the auditory prompts, and did not effectively learn that a food reward could
only be obtained 2 or 4 times per minute (for the low repetition or high repetition tasks,
respectively) despite more frequent pulling of the handle, although they did improve with
time (as reported next).
Reach rate declined (improved) towards target levels across weeks of task performance in
the group with the lowest force requirements (HRLF) and with ibuprofen treatment (HRHF
+IBU) (week, p<0.0001; group, p<0.0001; interaction, p=0.03) (Fig. 2). Specifically, reach
rate declined in HRLF rats in weeks 9 and 12, compared to their week 1 (p<0.01),
suggesting skill acquisition since it declined towards their target reach rate (from 5 to 3
times their target rate). However, reach rates in LRHF and untreated HRHF rats did not
differ with week into the protocol, and remained approximately 3 times more than their
target. In contrast, reach rate declined in 12-week HRHF+IBU rats, compared to week 1
(p<0.01), again suggesting skill acquisition since it declined towards their target rate (from 3
to 1.8 times their target). Compared across groups, reach rate was lower in week 1 in the
high force groups (LRHF, HRHF and HRHF+IBU) than in HRLF (p<0.01 each). Also in
week 1, LRHF rats had, appropriately, the lowest reach rate compared to the other groups
(p<0.01 each).
The reach force target of 15% was met by the low force group (HRLF) in week 12, while the
reach force target of 60% was met only by the ibuprofen treated group (HRHF+IBU) in
week 9, although they neared it in week 12 (week, n.s., p=0.16; group, p<0.0001;
interaction, p=0.007) (Fig. 3). Specifically, reach force declined towards the target force
level of 15% in HRLF rats in weeks 9 and 12, compared to week 1 (p<0.01 each). Since they
met target force level in week 12, this is indicative of skill acquisition. In contrast, reach
force did not change significantly in LRHF or HRHF rats in weeks 9 and 12 from week 1
levels, remaining below their target of 60% throughout the experiment (their reach force
ranged from 38–46%). However, reach force was greater in HRHF+IBU rats in weeks 9 and
12, than in week 1 (p<0.01 each). They reached their target force level of 60% in week 9,
declined to 52% in week 12 (Fig. 3). Concerning group differences, all high force rats
(LRHF, HRHF, HRHF+IBU) had, appropriately, higher reach force than HRLF in each
week (p<0.01 each). Lastly, in week 9, the HRHF+IBU rats had higher reach force than
LRHF (p<0.05) and untreated HRHF (p<0.01), the latter indicating an inflammatory
influence on reach force.
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Percent successful reaches increased in all groups with continued task performance, except
in the ibuprofen treated group (HRHF+IBU), which increased in week 9 but decreased in
week 12 (week, p=0.001; group, p<0.0001; interaction, p=0.001) (Fig. 4). Specifically,
compared to their week 1 levels, percent successful reaches increased in week 9 in HRLF,
LRHF, HRHF and HRHF+IBU (p<0.05 for HRLF, p<0.01 for the others), and in week 12 in
HRHF, each suggestive of skill acquisition. Surprisingly, HRHF+IBU rats had fewer
successful reaches in week 12, compared to their week 1 (p<0.01), indicating that ibuprofen
was only effective short-term. There were also differences by group, with the HRLF group
having lower percent success than each of the high force groups in week 9 (p<0.01 each),
and lower than HRHF in week 12 (p<0.01 each). Also, 12-week HRHF+IBU rats had fewer
successful reaches than 12-week HRHF rats (p<0.01).
The duration of voluntary task participation neared the target of 120 min per day only in the
low force group (HRLF) in week 1, and in the ibuprofen treated group (HRHF+IBU) in
weeks 9 and 12 (week, n.s., p=0.98; group, p<0.0001; interaction, p<0.0001) (Fig. 5).
Specifically, the duration of task participation declined in HRLF rats across weeks slightly,
but not significantly. Also, the duration of task participation in the LRHF rats decreased in
week 12 (p<0.01), and in the HRHF rats in weeks 9 (p<0.01) and 12 (p<0.05), compared to
their week 1 values, indicative of exposure-dependent declines (exposure defined here as
number of weeks exposed to the task). In contrast, duration increased in HRHF+IBU rats in
weeks 9 and 12, compared to week 1 (p<0.01 each), indicating an inflammatory influence on
duration. Concerning group differences, in week 1, the high force groups (LRHF, HRHF and
HRHF+IBU) had lower duration levels than the HRLF (p<0.01 each), as did LRHF in week
12 and HRHF in weeks 9 and 12 (p<0.01 each), indicating a force level influence on
duration. In contrast, duration increased in HRHF+IBU rats in weeks 9 and 12, compared to
LRHF and HRHF rats in weeks 9 and 12 (p<0.01), indicating that there was also an
inflammatory influence on duration.
Grip strength declined, bilaterally, in all groups with continued task performance and with
higher force requirements, and was only nominally attenuated by ibuprofen treatment (both
limbs: week, p<0.0001; group, p<0.0001; interaction, p=0.0009) (Fig. 6). Specifically, in the
preferred reach limb (Fig. 6A), grip strength declined in all groups in weeks 9 and 12,
compared to baseline naïve levels (p<0.01 each). Concerning group differences, grip
strength was lower in the reach limbs of the high force groups (LRHF, HRHF and HRHF
+IBU) in week 9 compared to 9-week HRLF rats, and in 12-week HRHF rats compared to
12-week HRLF (p<0.01 each), indicative of a force level influence on grip strength.
Ibuprofen treatment did not improve grip strength in the reach limb in HRHF+IBU rats
above HRHF levels (p>0.05, n.s.), although they were equivalent to HRLF rats by week 12
rather than lower, as seen in week 9.
In the contralateral support limb, a limb used for postural support against the chamber wall,
grip strength also decreased in all groups in weeks 9 and 12, compared to baseline levels
(p<0.01 each, Fig. 6B). Concerning group differences, grip strength was lower in the HRHF
group in this limb in 9-week HRHF rats than 9-week HRLF (p<0.05), and lower than all
other groups in week 12 (p<0.01 each). Two-tailed t-tests confirmed that 9-week LRHF and
9-week HRHF+IBU rats did not have grip strengths that were significantly different from 9-
week HRLF rats. These findings indicate that the level of postural support “push” used by
HRHF rats affected their grip strength more than in the other groups. Grip strength was
higher in 12-week HRHF+IBU rats than 12-week HRHF rats (p<0.01), although still lower
than baseline levels, indicating that grip strength was only partially influenced by
inflammation in this limb.
Kietrys et al. Page 7













We next examined cervical spinal cord segments for evidence of increased IL-1beta, a pro-
inflammatory cytokine, and found increased IL-1beta immunoreactivity in neurons (NeuN+)
in the intermediate and ventral horns of 12-week HRHF rats (Fig. 7A,B), but not in normal
control rats (Fig. 7C). Ibuprofen treatment for 8 weeks did not attenuate IL-1beta
immunoreactivity in 12-week HRHF+IBU rat (Fig. 7D), indicating that oral dosing with this
anti-inflammatory drug did not attenuate this central nervous system inflammatory response.
Similar results were observed in all animals examined (n=4/group). This finding suggests
that neuroplastic changes may be contributing to the grip strength declines.
Discussion
Our results show that some behaviors, such as reach rate and reach force improved, at least
partially, in rats performing the lower force task (HRLF) and in ibuprofen treated rats
(HRHF+IBU). Percent successful reaches also improved in all groups, except the 12-week
HRHF+IBU rats. Percent success decreased less with the lower force task, in general, than
with the high force tasks. Other behaviors, such as the ability or willingness to participate
fully in the task (duration) and grip strength, showed exposure-dependent declines, with
greater declines in the untreated high force groups. Ibuprofen treatment greatly improved
reach rate, reach force and duration, indicating an inflammatory influence on these
behaviors. However, ibuprofen treatment did not rescue grip strength declines to baseline
levels, and only nominally improved grip strength above untreated HRHF levels. There was
an increase in IL-1beta immunoreactivity in neurons located in cervical spinal cords of both
HRHF and HRHF+IBU rats that was not responsive to ibuprofen treatment that might have
contributed to the persistent declines in grip strength.
Behaviors that improved with skill acquisition
Reach rate, the average number of both successful and unsuccessful reaches per minute,
showed improvement only in the low force (HRLF) and ibuprofen treated (HRHF+IBU)
groups. The HRLF rats dropped from exceeding their target rate of 4 reaches/min by five
fold to three fold (although still in excess), and the HRHF+IBU rats dropped from 3 fold to
1.8 fold. We have previously reported a transient declines in reach rate after exposure to the
HRHF handle pulling task, compared to week 1 (Clark et al., 2004). In retrospect, although
we previously described these decline as impairments, perhaps declines in reach rate with
the handle-pulling task are due to skill acquisition. In HRLF rats, a 1.6 fold decline in reach
rate was matched by a 1.8 fold improvement in percent successful reaches. Over time, rats
presumably learned the meaning of the auditory cues that preceded the start of each reach
phase, increased their ability to control the applied force, or a combination of the two. The
lower reach rates in the high force groups, in general, than the low force group, may also be
due to a greater ease of force modulation when near maximum voluntary force levels.
However, reach rates did not improve in the high force groups, except in the HRHF+IBU
group, presumably due to reduction in discomfort from task-induced tissue inflammation.
Discomfort likely prevented the LRHF and untreated HRHF from modulating their reaching
effectively.
Reach force also showed improvement in the HRLF and HRHF+IBU groups. The HRLF
rats, for example, met their target requirement of 15% maximum pulling force by week 12.
Ballermann, Thomkins, and Whishaw (2000) reported that rats can modify and correct their
reach force with experience when learning a skilled reaching and grasping task. Apparently,
though, there is a limit to rats’ ability to correct their reach force, as we observed no
improvement in the LRHF or untreated HRHF groups with continued task performance.
These findings combined suggest that it is easier to reach the 15% force level than the 60%
force level. Only HRHF+IBU rats were able to reach their target of 60% maximum pulling
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force in week 9. However, despite continued ibuprofen treatment, they were unable to
maintain this hypothesized correction, and declined to 52% in week 12.
Each group showed an increase in percent successful reaches in week 9, with or without
improvements in reach rate or force, an improvement maintained through week 12 in HRLF
and HRHF rats. Since no food reward was delivered if the rats undershot their minimum
criterion (−5% of their target force) or overshot their maximum criterion (+5% of their target
force), and since only HRLF and HRHF+IBU rats showed improved reach force, an ability
to correct reach force with experience was not the key factor contributing to success. The
rats also had to reach within the right time frame and hold the handle for 50ms to receive a
food reward. That skill was achieved by all but the 12-week HRHF+IBU rats. Their ability
to pull at a reach force of 52% in week 12 rules out muscle fatigue. Although this may seem
counterintuitive, perhaps the rats with the greater levels of exposure (and thus the greatest
amount of tissue injury and inflammation), were honing their attention in order to maximize
their efficiency of movement to avoid any unnecessary movements and/or discomfort.
Ibuprofen treatment in the HRHF+IBU rats may have reduced that attention by week 12.
This idea may also explain the low percent success in the HRLF rats. Whatever the reason
for the lower success in 12-week HRHF+IBU and HRLF rats, consistent maintenance of a
reach force of approximately 40–46% by the LRHF and untreated HRHF rats throughout the
weeks of task performance was a more successful strategy with respect to percent successful
reaching.
Behaviors that decline with exposure (continued task performance and/or level of task)
Despite the acquisition of greater skill, decreased duration in the two high force groups
(LRHF and HRHF) suggests fatigue and/or diminished tolerance for continuation of activity.
This is consistent with findings in our prior studies in which rats performing high force tasks
show exposure-induced declines in duration (Clark et al., 2004; Elliott et al., 2009b) declines
not observed in rats performing negligible force tasks (Coq et al., 2009; Elliott et al., 2008).
These findings combined indicate that high force tasks are more difficult to sustain than low
force tasks. Also, the more pronounced declines with HRHF than with the HRLF or LRHF
groups suggest that force magnitude and repetition have a combined effect. Ibuprofen
treatment in the HRHF+IBU rats ameliorated this decline in duration. In fact, duration was
close to 100% in the HRHF+IBU group, even higher than the HRLF group. This suggests
that there is an inflammatory component to declines in duration.
We also observed grip strength declines in all groups in weeks 9 and 12, with greater
declines in the high force groups than the low force group. In general, HRHF rats had the
lowest grip strengths. These findings are indicative of force-dependent declines in grip
strength. We have also reported repetition-dependent declines in the past, with lower grip
strengths in rats performing a high repetition, negligible force task than a low repetition,
negligible force task (Barbe et al, 2008). The declines in grip strength were bilateral, since,
as shown previously, the contralateral (nonreach) limb is used for postural support against
the chamber wall (Fedorczyk et al., 2010). The push activity of the support limb apparently
decreased grip strength more than the isometric pull by the reach limb, indicating that the
use of other body regions for postural support can also affect function in that limb.
Behavioral declines linked to inflammatory responses
Several of the reach performance variables improved in the HRHF+IBU rats, including
reach rate, reach force, duration and percent success, albeit the latter only in 9-week HRHF
rats. These findings provide additional evidence that inflammation is one of the mechanisms
related to declines in motor function with repetitive tasks. This hypothesis is further
supported by studies from our lab and others that report reduced success, duration, grip
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strength, and reflexive limb withdrawal to mechanical stimuli are associated with increased
inflammatory cells, cytokines, and nociceptor-related neurochemicals in peripheral tissues
and serum (Barbe et al., 2008; Clark et al., 2004; Elliott et al., 2009a,b; Elliott et al., 2010;
Fedorczyk et al., 2010; Schafers et al., 2003; Beyreuther et al., 2007). It has also been shown
that declines in grip strength occur after injection of TNF into forearm muscles (Beyreuther
et al., 2007). Inflammation linked declines in grip strength have been termed muscle
hyperalgesia, and may be a form of myalgia. In our model, grip strength declines improved
after treatment with an anti-rat TNF drug in weeks 5–6 of a 6 week HRHF task, although
similar to these current findings, grip strength did not return to baseline levels (Rani et al.,
2010).
On the other hand, we recently reported persistent declines in grip strength in young adult
HRLF rats in which the circulating inflammatory response had resolved (Xin et al., 2011).
Those results combined with our current findings indicate that anti-inflammatory
medication, such as ibuprofen, may be effective only during the early management of
repetitive motion injuries. This is particularly true since ibuprofen use may affect muscle
negatively (Machida & Takemasa, 2010; Soltow et al., 2006). Thus, factors other than
inflammation must also contribute to persistent grip strength declines.
This is a concern since non-steroidal anti-inflammatory drugs (NSAIDS), including
ibuprofen, are commonly used (self-care and prescribed) for both acute and chronic
musculoskeletal pain (Anthony, Martin, Avery & Williams, 2010; Beebe, Barkin & Barkin,
2005; Bouef-Calnan, Lapeyre-Mestre, Niezborala & Montastruc, 2007; Curatolo and
Bogduk, 2011; Krause, Scherzer & Rugulies, 2005; Lashuay, Burgel, Harrion, Israel, et al,
2002; Martin, Levenson, Hollingworth, Kliot, et al, 2005). The first line of treatment of
upper extremity limb pain by practioners usually entails a prescription of NSAIDS (Clarke,
2001; Lashuay et al, 2002). Krause et al (2005) found in a survey study that 84% of 941
workers used NSAIDS, including ibuprofen, for pain. Forty percent of 2213 French workers
reported the regular use of ibuprofen in a one month period (Bouef-Cazou et al, 2009). Back
and shoulder injuries and other musculoskeletal strains are largely self-treated by migrant
farm workers with rest and over-the-counter drugs, such as ibuprofen (Anthony et al, 2010).
However, as best stated by Curatolo and Bogduk (2011), “the results [for commonly used
drugs} are sobering, if not disconcerting”. Our results match those of several clinical trials,
that NSAIDS have short-term effectiveness, but not long-term, for chronic musculoskeletal
conditions with pain.
Behaviors that decline due to maladaptive central nervous system neuroplasticity
We postulate that the increased IL-1beta immunoreactivity in ventral horn neurons observed
here contribute to the persistent grip strength declines. These observations match a recent
report from our lab in which we observed that two pro-inflammatory cytokines, TNF-alpha
and IL-1beta, increase in neurons in the dorsal horns of cervical spinal cord segments of
aged rats performing a HRLF task (Elliott et al., 2010). These increases correlated positively
with enhanced nocifensive behaviors, including declines in grip strength (Elliott et al.,
2009b). We have also reported that Substance P and its receptor, neurokinin 1, increase in
cervical spinal cord segments, in conjunction with increased peripheral inflammation, in rats
performing repetitive tasks (Elliott et al., 2008; Elliott et al., 2009a; Elliott et al., 2009b;
Elliott et al., 2010). Again, these increases correlated with declines in grip strength.
Increased neurochemicals and inflammatory cytokines in spinal cord neurons are
characteristics of central sensitization, an enhancement of neuronal sensitivity and
neuropathic pain (Woolf and Salter, 2000). Thus, pain or discomfort as a result of central
sensitization is likely contributing to declines in grip strength.
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Several studies also indicate that maladaptive neuroplasticity in the somatosensory cortex
contributes to motor declines (Ballermann, McKenna & Whishaw, 2001; Byl & Melnick,
1997; Byl et al., 1997; Byl et al., 1996; Coq et al., 2009). Disruption of the forepaw map and
the emergence of large receptive fields in the somatosensory cortex resulted in involuntary
movements characteristic of focal hand dystonia in a monkey model of repetitive prehensile
tasks (Byl et al., 1997; Byl et al., 1996). In our model, performance of a repetitive negligible
force reaching task for 8 weeks also resulted in disruption of the forepaw map in the
somatosensory cortex, as well as the emergence of large receptive fields encompassing
several forepaw subdivisions, such as digits-pads and forepaw-forearm (Coq et al, 2009).
The larger receptive fields correlated negatively with percent successful reaches. Thus,
somatosensory cortical changes likely result in ambiguous interpretation of tactile cues and
contribute to declines in grasp control.
Changes in the motor cortex were also detected in the Coq study mentioned above (Coq et
al., 2009). These changes included enlarged motor forepaw maps and increased
representation of digit and multi-joint movements. Some of these changes seemed more
adaptive than deleterious, and likely contribute to our observed skill acquisition. This is
supported by studies showing that motor skill learning is associated with expansion of the
representation of distal forelimb movements in the motor cortex (Kleim, Barbay & Nudo,
1998; Plautz, Milliken & Nudo, 2000). However, we also observed increased pathological
multi-joint movements when stimulating motor cortex neurons in our past study (Coq et al,
2009), and that the amount of current needed to evoke these multi-joint movements was
lower than in controls. These changes correlated positively with increased inflammatory
cytokines in the forearm muscles, suggestive of a peripheral tissue inflammation influence
on the motor cortex. These results combined provide strong evidence that peripheral
inflammation, spinal cord neuroplasticity and cortical neuroplasticity contribute to the
development of motor declines as well as skill acquisition observed with chronic repetitive
motion tasks.
Conclusions
Using a rat model of voluntary reaching and handle-pulling, in which rats perform repetitive
tasks for 12 weeks (2 h/day in 30 min sessions, 3 days/wk) with low or high repetition
requirements, combined with high or low force requirements, we observed that repetitive
motion tasks have adverse, exposure-dependent effects on some indicators of motor
behavior. However, these changes were likely to be superimposed upon other changes in
motor behavior, such as those indicative of skill acquisition. It is clear that when greater
force requirements were combined with a highly repetitive task, the adverse effects on motor
performance were magnified. Treatment with ibuprofen helped to ameliorate some of the
adverse effects on motor performance, providing further support that inflammation is a
critical component of the pathophysiology of repetitive motion injury. However, anti-
inflammatory medication was not a complete solution to a complex multi-system problem.
Although the findings of animal models of WMSDs cannot be directly generalized to human
workers, the findings of such studies provide strong evidence of a complex
pathophysiological process that involves multiple systems and tissues and leads to motor
decline. Because the pathophysiology of repetitive motion injury is complex, the most
effective therapeutic approach needs to be multifaceted. However, it is quite clear that
earlier or preventive interventions are needed to avoid persistent motor dysfunction.
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Experimental design and number of animals per group. Ninety-two rats were trained for 10–
15 min/day for 5–6 weeks to learn one of four tasks, and then performed this task for 2 hr/
day, 3 days/week for 12 weeks. LRHF = low repetition with high force task group. HRLF =
High repetition with low force task group. HRHF = high repetition with high force task
group. HRHF+IBU = HRHF rats that received ibuprofen treatment in last 8 weeks of task
performance. Four normal control rats were included that were not exposed to the training or
to the task. The training period that preceeded the task period is indicated by dashed lines.
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Reach Rate (number of all successful and unsuccessful reaches/minute). Across weeks of
task performance, reach rate declined towards the target of 4 reaches/min in the HRLF and
HRHF+IBU groups, but not in the LRHF and HRHF groups. Group differences were also
detected: In week 1, HRHF and HRHF+IBU groups had lower reach rates than HRLF, and
the LRHF group (the group with the lowest target reach rate), had lowest rate. Dashed lines
show target reach rates for high repetition (HR, 4 reaches/min) and low repetition (LR, 2
reaches/min), as indicated. Arrow indicates onset of ibuprofen treatment (IBU) at end of
week 4. 1 = p<0.01 compared to week 1 of same group; 2 = p<0.01 compared to same week
HRLF; 3 = p<0.01 compared to same week LRHF, 4 = p<0.01 compared to same week
HRHF.
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Reach Force on handle (percent of maximum pulling force, MPF). Across weeks of task
performance, reach force declined in HRLF towards their target of 15% and met that target
in week 12. Likewise, reach force increased in HRHF+IBU rats to their target of 60% in
week 9, although it dropped to 52% in week 12, which was still significantly higher than in
week 1. The reach force did not change across weeks in the LRHF and HRHF groups, and
remained lower than the target. Group differences were also detected: HRHF+IBU had the
highest reach force in week 9. Reach force was appropriately higher in the high force groups
than the low force group. Dashed lines show target reach forces for low force (LF; 15%) and
high force (HF; 60%), as indicated. Arrow indicates onset of ibuprofen treatment (IBU) at
end of week 4. 1 = p<0.01 compared to week 1 of same group; 2 = p<0.01 compared to
same week HRLF; 3* = p<0.05 compared to same week LRHF; 4 = p<0.01 compared to
same week HRHF.
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Percent Successful Reaches (of all reaches). Percent successful reaches increased in all
groups in week 9, and in HRLF and HRHF in week 12, compared to week 1. In contrast,
HRHF+IBU rats had decreased success in week 12. Group differences were also detected:
percent success was greater in all high force groups than the HRLF in week 9, but lower in
HRHF+IBU rats than HRHF in week 12. Arrow indicates onset of ibuprofen treatment
(IBU) at end of week 4. 1 and 1* = p<0.01 and p<0.05, respectively, compared to week 1 of
same group; 2 = p<0.01 compared to same week HRLF; 4 = p<0.01 compared to same week
HRHF.
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Duration of task participation (as a percent of the target of 120 min/day). Across the weeks,
duration decreased in the HRHF and LRHF groups. In contrast, duration dramatically
increased in HRHF+IBU rats in weeks 9 and 12, compared to their week 1. Group
differences were also detected: Duration was lower in all high force groups than the HRLF
group in week 1, and lower in the LRHF and HRHF groups than the HRLF group in weeks 9
and 12. In contrast, duration was dramatically increased in HRHF+IBU rats in weeks 9 and
12, compared to the other high force groups. Dashed line indicates target duration of 120
minutes (100%). Arrow indicates onset of ibuprofen treatment (IBU) at end of week 4. 1 and
1* = p<0.01 and p<0.05, respectively, compared to week 1 of same group; 2 = p<0.01
compared to same week HRLF; 3 = p<0.01 compared to same week LRHF; 4 = p<0.01
compared to same week HRHF.
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Grip strength (maximum reflexive grip strength in grams (g)). (A) Preferred reach limb. In
weeks 9 and 12, grip strength was decreased in this limb in all groups, compared to baseline
naïve levels. Grip strength was also lower in week 9 in all high force groups, and in the
HRHF group in week 12, than in the HRLF group. (B) Contralateral support limb. In weeks
9 and 12, grip strength was decreased in this limb in all groups, compared to baseline naïve
levels. Grip strength was also lower in the HRHF group in weeks 9 and 12 than in the HRLF
group, and lower than in HRHF+IBU in week 12. Arrow indicates onset of ibuprofen
treatment (IBU) at end of week 4. 1 = p<0.01 compared to week 1 of same group; 2 and 2*
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= p<0.01 and p<0.05, respectively, compared to same week HRLF; 3 = p<0.01 compared to
same week LRHF; 4 = p<0.01 compared to same week HRHF.
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Inflammatory cytokine immunohistochemical expression in spinal cords. (A) Representative
photograph of a cervical spinal cord in cross section showing IL-1beta staining (green
staining) in the intermediate and ventral horns of HRHF rats. Inset shows higher power
stained cells indicated. (B) Same section as shown in panel A showing that IL-1beta stained
cells (green staining) are double-labeled for NeuN, a neuronal cell body marker (red
staining). (C) A cervical spinal cord segment from a control rat showing a near absence of
staining for IL-1beta. (D) A cervical spinal cord segment from a HRHF+IBU rat showing
the presence of IL-1beta stained cells. Scale bar = 50 micrometers. Similar staining was
observed in 4 animals/group.
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